HF
PRME icon

HRT Financial’s Prime Medicine PRME Stock Holding History

HRT Financial’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13M Sell
612,769
-42,582
-6% -$162K 0.01% 1581
2025
Q4 		$2.27M Buy
655,351
+433,887
+196% +$1.93M 0.01% 1222
2025
Q3 		$1.23M Buy
221,464
+157,297
+245% +$639K ﹤0.01% 1421
2025
Q2 		$158K Buy
+64,167
New +$98.9K ﹤0.01% 2125
2025
Q1 		– Sell
-21,695
Closed -$63K – 3215
2024
Q4 		$63K Buy
+21,695
New +$76.2K ﹤0.01% 2088
2024
Q2 		– Sell
-41,000
Closed -$287K – 2917
2024
Q1 		$287K Sell
41,000
-18,116
-31% -$137K ﹤0.01% 1582
2023
Q4 		$523K Buy
+59,116
New +$455K ﹤0.01% 1337

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

HRT Financial's PRME Position: Q1 2026 in Review

HRT Financial reduced its Prime Medicine (PRME) stake by 6.5% in Q1 2026, selling an estimated $162K and leaving 612,769 shares worth $2.13M. The position accounts for 0.01% of the portfolio, ranked #1581.

HRT Financial first reported a position in PRME in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.27M in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • HRT Financial held 612,769 shares of Prime Medicine worth $2.13M as of Q1 2026.
  • HRT Financial sold 42,582 Prime Medicine shares in Q1 2026, an estimated $162K.
  • Prime Medicine made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1581 holding.
  • HRT Financial first reported a position in Prime Medicine in Q4 2023 and has held it in 7 quarters since.
  • HRT Financial's Prime Medicine position peaked at $2.27M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.